4.6 Article

Indian-Subcontinent NBIA: Unusual Phenotypes, Novel PANK2 Mutations, and Undetermined Genetic Forms

期刊

MOVEMENT DISORDERS
卷 25, 期 10, 页码 1424-1431

出版社

WILEY
DOI: 10.1002/mds.23095

关键词

dystonia; Parkinson's disease; neurodegeneration with brain iron accumulation; eye-of-the-tiger sign; MRI

资金

  1. Parkinson's Disease Foundation of India
  2. University of Luebeck, Germany [E48.2009]
  3. Novartis Foundation
  4. Medical Research Council (MRC)
  5. Bachmann Strauss Foundation
  6. Michael J Fox Foundation
  7. Brain Research Trust (BRT)
  8. National Organization for Rare Disorders (NORD)
  9. Ataxia UK
  10. BMA Vera Down Award
  11. Hermann and Lilly Schilling Foundation
  12. Department of Health's National Institute for Health Research Biomedical Research Centers
  13. Orion
  14. Teva
  15. Dystonia Society, UK
  16. Halley Stewart Trust
  17. MRC [G0701075, G0802760] Funding Source: UKRI
  18. Medical Research Council [G0802760, G0701075] Funding Source: researchfish
  19. Parkinson's UK [G-0907] Funding Source: researchfish

向作者/读者索取更多资源

Neurodegeneration with brain iron accumulation (NBIA) is etiologically, clinically, and by imaging a heterogeneous group including NBIA types I [pantothenate kinase-associated neurodegeneration (PKAN)] and 2 (PLA2G6-associated neurodegeneration), neuroferritinopathy, and aceruloplasminaemia. Data on genetically defined Indian-subcontinent NBIA cases are limited. We report 6 patients from the Indian-subcontinent with a movement disorder and MRI basal ganglia iron deposition, compatible with diagnosis of an NBIA syndrome. All patients were screened for abnormalities in serum ceruloplasmin and ferritin levels and mutations in NBIA-associated genes [pantothenate kinase 2 (PANK2), PLA2G6 and ferritin light chain (exon 4)]. We present clinical, imaging and genetic data correlating phenotype genotype relations. Four patients carried PANK2 mutations, two of these were novel. The clinical phenotype was mainly dystonic with generalized dystonia and marked orobulbar features in the 4 adolescent-onset cases. One of the four had a late-onset (age 37) unilateral jerky postural tremor. His mutation, c.1379C>T, appears associated with a milder phenotype. Interestingly, he developed the eye-of-the-tiger sign only 10 years after onset. Two of the six presented with adult-onset levodopa (L-dopa)-responsive asymmetric re-emergent rest tremor, developing L-dopa-induced dyskinesias, and good benefit to deep brain stimulation (in one), thus resembling Parkinson's disease (PD). Both had an eye-of-the-tiger sign on MRI but were negative for known NBIA-associated genes, suggesting the existence of further genetic or sporadic forms of NBIA syndromes. In conclusion, genetically determined NBIA cases from the Indian subcontinent suggest presence of unusual phenotypes of PANK2 and novel mutations. The phenotype of NBIA of unknown cause includes a PD-like presentation. (C) 2010 Movement Disorder Society

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage

Ghil Schwarz, Gargi Banerjee, Isabel C. Hostettler, Gareth Ambler, David J. Seiffge, Hatice Ozkan, Simone Browning, Robert Simister, Duncan Wilson, Hannah Cohen, Tarek Yousry, Rustam Al-Shahi Salman, Gregory Y. H. Lip, Martin M. Brown, Keith W. Muir, Henry Houlden, Rolf Jager, David J. Werring

Summary: This study found associations between putative biomarkers of parenchymal CAA and putative biomarkers of leptomeningeal CAA, and suggested that CT biomarkers may help in diagnosing CAA, but MRI still plays an important role in ICH survivors with suspected CAA.

INTERNATIONAL JOURNAL OF STROKE (2023)

Review Clinical Neurology

Childhood-Onset Choreo-Dystonia Due to a Recurrent Novel Homozygous Nonsense HPCA Variant: Case Series and Literature Review

Francesca Magrinelli, Kailash P. Bhatia, Mehran Beiraghi Toosi, Fatemeh Arab, Ehsan Ghayoor Karimiani, Sahar Sedighzadeh, Behnaz Ansari, Maedeh Neshatdoust, Clarissa Rocca, Henry Houlden, Reza Maroofian

Summary: This article reports a new phenotype of childhood-onset choreo-dystonia in four patients from two unrelated Iranian pedigrees, who harbor a novel pathogenic variant in the HPCA gene. A systematic review of the literature reveals that HPCA-related dystonia can present as an isolated condition or in combination with various symptoms. Most cases show a poor or no response to common antidystonic medications.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

De novo KCNA6 variants with attenuated KV1.6 channel deactivation in patients with epilepsy

Vincenzo Salpietro, Valentina Galassi Deforie, Stephanie Efthymiou, Emer O'Connor, Anna Marce-Grau, Reza Maroofian, Pasquale Striano, Federico Zara, Michelle M. Morrow, Adi Reich, Amy Blevins, Julia Sala-Coromina, Andrea Accogli, Sara Fortuna, Marie Alesandrini, P. Y. Billie Au, Nilika Shah Singhal, Benjamin Cogne, Bertrand Isidor, Michael G. Hanna, Alfons Macaya, Dimitri M. Kullmann, Henry Houlden, Roope Mannikko

Summary: Novel mutations in KCNA6 gene were found to be associated with early infantile epileptic phenotypes and neurodevelopmental anomalies. Functional characterization revealed that these mutations affect channel closure and voltage dependence. This study is the first to report the association between de novo variants in KCNA6 and neurological features.

EPILEPSIA (2023)

Article Clinical Neurology

Genetic variation in NFE2L2 is associated with outcome following aneurysmal subarachnoid haemorrhage

Ben Gaastra, Poppy Duncan, Mark K. Bakker, Isabel C. Hostettler, Varinder S. Alg, Henry Houlden, Ynte M. Ruigrok, Ian Galea, Will Tapper, David Werring, Diederik Bulters

Summary: This study found that genetic variation in nuclear factor erythroid 2-related factor 2 (NRF2) is associated with clinical outcome following aneurysmal subarachnoid haemorrhage (aSAH), indicating a clinically relevant pathophysiological role for oxidative and inflammatory brain injury in aSAH. The findings also suggest NRF2 as a potential therapeutic target for aSAH and other forms of intracranial haemorrhage.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Genetics & Heredity

Biallelic PRMT7 pathogenic variants are associated with a recognizable syndromic neurodevelopmental disorder with short stature, obesity, and craniofacial and digital abnormalities

Elisa Cali, Mohnish Suri, Marcello Scala, Matteo P. Ferla, Shahryar Alavi, Eissa Ali Faqeih, Emilia K. Bijlsma, Kristen M. Wigby, Diana Baralle, Mohammad Y. Mehrjardi, Jennifer Schwab, Konrad Platzer, Katharina Steindl, Mais Hashem, Marilyn Jones, Dmitriy M. Niyazov, Jennifer Jacober, Rebecca Okashah Littlejohn, Denisa Weis, Neda Zadeh, Lance Rodan, Alice Goldenberg, Francois Lecoquierre, Marina Dutra-Clarke, Gabriella Horvath, Dana Young, Naama Orenstein, Shahad Bawazeer, Anneke T. Vulto-van Silfhout, Yvan Herenger, Mohammadreza Dehghani, Seyed Mohammad Seyedhassani, Amir Bahreini, Mahya E. Nasab, A. Gulhan Ercan-Sencicek, Zahra Firoozfar, Mojtaba Movahedinia, Stephanie Efthymiou, Pasquale Striano, Ehsan Ghayoor Karimiani, Vincenzo Salpietro, Jenny C. Taylor, Melody Redman, Alexander P. A. Stegmann, Andreas Laner, Ghada Abdel-Salam, Megan Li, Mario Bengala, Amelie Johanna Muller, Maria C. Digilio, Anita Rauch, Murat Gunel, Hannah Titheradge, Daniela N. Schweitzer, Alison Kraus, Irene Valenzuela, Scott D. McLean, Chanika Phornphutkul, Mustafa Salih, Amber Begtrup, Rhonda E. Schnur, Erin Torti, Tobias B. Haack, Carlos E. Prada, Fowzan S. Alkuraya, Henry Houlden, Reza Maroofian

Summary: PRMT7-related syndrome is a neurodevelopmental disorder characterized by short stature, intellectual developmental disability, hypotonia, brachydactyly, and distinct facial morphology. This study provides a comprehensive description of the clinical characteristics of this syndrome, contributing to a better understanding of the disease.

GENETICS IN MEDICINE (2023)

Article Genetics & Heredity

Expanding SPTAN1 monoallelic variant associated disorders: From epileptic encephalopathy to pure spastic paraplegia and ataxia

Heba Morsy, Mehdi Benkirane, Elisa Cali, Clarissa Rocca, Kristina Zhelcheska, Valentina Cipriani, Evangelia Galanaki, Reza Maroofian, Stephanie Efthymiou, David Murphy, Mary O'Driscoll, Mohnish Suri, Siddharth Banka, Jill Clayton-Smith, Thomas Wright, Melody Redman, Jennifer A. Bassetti, Mathilde Nizon, Benjamin Cogne, Rami Abu Jamra, Tobias Bartolomaeus, Marion Heruth, Ilona Krey, Janina Gburek-Augustat, Dagmar Wieczorek, Felix Gattermann, Meriel Mcentagart, Alice Goldenberg, Lucie Guyant-Marechal, Hector Garcia-Moreno, Paola Giunti, Brigitte Chabrol, Severine Bacrot, Roger Buissonniere, Virginie Magry, Vykuntaraju K. Gowda, Varunvenkat M. Srinivasan, Bela Melegh, Andras Szabo, Katalin Sumegi, Mireille Cossee, Monica Ziff, Russell Butterfield, David Hunt, Georgina Bird-Lieberman, Michael Hanna, Michel Koenig, Michael Stankewich, Jana Vandrovcova, Henry Houlden

Summary: The purpose of this study was to understand the phenotypic spectrum of SPTAN1 variants. It was found that SPTAN1 variants were significantly enriched in families with hereditary ataxia or hereditary spastic paraplegia. A total of 31 individuals with SPTAN1 variants were identified, with 10 patients presenting with pure or complex HSP/HA and the remaining 21 patients having developmental delay and seizures. Fibroblasts derived from two patients showed irregular alpha II-spectrin aggregation.

GENETICS IN MEDICINE (2023)

Article Genetics & Heredity

Biallelic variants in OGDH encoding oxoglutarate dehydrogenase lead to a neurodevelopmental disorder characterized by global developmental delay, movement disorder, and metabolic abnormalities

Ella F. Whittle, Madison Chilian, Ehsan Ghayoor Karimiani, Helga Progri, Daniela Buhas, Melis Kose, Rebecca D. Ganetzky, Mehran Beiraghi Toosi, Paria Najarzadeh Torbati, Reza Shervin Badv, Ivan Shelihan, Hui Yang, Houda Zghal Elloumi, Sukyeong Lee, Yalda Jamshidi, Alan M. Pittman, Henry Houlden, Erika Ignatius, Shamima Rahman, Reza Maroofian, Wan Hee Yoon, Christopher J. Carrol

Summary: This study aimed to identify the genetic cause of a novel autosomal recessive neurodevelopmental disorder characterized by global developmental delay, movement disorder, and metabolic abnormalities. Through clinical characterization and genetic analysis, the researchers identified three novel homozygous variants in the OGDH gene. Functional studies demonstrated that these variants interfered with the structure and function of the OGDH protein, leading to the observed neurodevelopmental disorder. This research highlights the importance of studying genetic causes of neurodevelopmental disorders for understanding their underlying mechanisms and developing targeted therapies.

GENETICS IN MEDICINE (2023)

Article Neurosciences

Human myeloid progenitor glucocorticoid receptor activation causes genomic instability, type 1 IFN- response pathway activation and senescence in differentiated microglia; an early life stress model

Jingzhang Wei, Charles Arber, Selina Wray, John Hardy, Thomas M. M. Piers, Jennifer M. M. Pocock

Summary: One type of early life stress, prenatal exposure to glucocorticoids (GCs), increases the risk of psychiatric and neurodevelopmental disorders in later life. Microglial cells are being increasingly recognized for their importance in these disorders. However, research on GCs exposure during microglial development is limited, especially in human studies. In this study, an in vitro model of early life stress was established by pre-exposing human iPS-microglia to GCs during primitive hematopoiesis, and the effects on microglial phenotype were examined. The findings suggest that prolonged GCs exposure during primitive hematopoiesis leads to changes in the matured iPS-microglia, potentially contributing to ELS-associated disorders.
Article Neurosciences

The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases

Zhongbo Chen, Regina H. Reynolds, Antonio F. Pardinas, Sarah A. Gagliano Taliun, Wouter van Rheenen, Kuang Lin, Aleksey Shatunov, Emil K. Gustavsson, Isabella Fogh, Ashley R. Jones, Wim Robberecht, Philippe Corcia, Adriano Chio, Pamela J. Shaw, Karen E. Morrison, Jan H. Veldink, Leonard H. van den Berg, Christopher E. Shaw, John F. Powell, Vincenzo Silani, John A. Hardy, Henry Houlden, Michael J. Owen, Martin R. Turner, Mina Ryten, Ammar Al-Chalabi

Summary: This study found that Neanderthal DNA introgression does not contribute to the genetic risk of neurodegenerative disorders in anatomically-modern humans. Additionally, there is no evidence to support the idea that common variants associated with these disorders are maintained by natural selection. These findings provide valuable insights into the origins of neurodegenerative diseases and address longstanding debates.

NEUROBIOLOGY OF DISEASE (2023)

Article Multidisciplinary Sciences

Analysis of subcellular RNA fractions demonstrates significant genetic regulation of gene expression in human brain post-transcriptionally

Karishma D'Sa, Sebastian Guelfi, Jana Vandrovcova, Regina H. Reynolds, David Zhang, John Hardy, Juan A. Botia, Michael E. Weale, Sarah A. Gagliano Taliun, Kerrin S. Small, Mina Ryten

Summary: This study revealed that the genetic regulation of gene expression mainly occurs post-transcriptionally in the cytoplasm, with synaptic genes more likely to undergo this form of regulation. These findings are crucial for understanding the structure of gene expression regulation in the human brain and interpreting large-scale gene association studies.

SCIENTIFIC REPORTS (2023)

Editorial Material Biochemistry & Molecular Biology

PINK1: From Parkinson's disease to mitophagy and back again

Benjamin O'Callaghan, John Hardy, Helene Plun-Favreau

Summary: The genetics of Parkinson's disease has played a crucial role in understanding the PINK1-dependent mitophagy process. In this article, we examine the implications of a 2010 PLOS Biology paper that provided insight into the functional significance of PINK1 in the mitophagy cascade.

PLOS BIOLOGY (2023)

Article Genetics & Heredity

eQTL Catalogue 2023: New datasets, X chromosome QTLs, and improved detection and visualisation of transcript-level QTLs

Nurlan Kerimov, Ralf Tambets, James D. Hayhurst, Ida Rahu, Peep Kolberg, Uku Raudvere, Ivan Kuzmin, Anshika Chowdhary, Andreas Vija, Hans J. Teras, Masahiro Kanai, Jacob Ulirsch, Mina Ryten, John Hardy, Sebastian Guelfi, Daniah Trabzuni, Sarah Kim-Hellmuth, William Rayner, Hilary Finucane, Hedi Peterson, Abayomi Mosaku, Helen Parkinson, Kaur Alasoo

Summary: The eQTL Catalogue is an open database of uniformly processed human molecular quantitative trait loci (QTLs) that has been continuously updated to improve its utility in interpreting genetic associations with complex traits. The updates include an increase in the number of studies and datasets covered, implementation of statistical fine mapping, and development of static QTL coverage plots. These updates have been demonstrated to be useful in interpreting genetic variants associated with vitamin D levels in human plasma and will facilitate the interpretation of complex trait associations identified by other human genetics efforts.

PLOS GENETICS (2023)

Letter Clinical Neurology

Anti-amyloid therapies work for Alzheimer's disease

John Hardy

BRAIN COMMUNICATIONS (2023)

Review Clinical Neurology

Multiple system atrophy

Yee Yen Goh, Emma Saunders, Samantha Pavey, Emma Rushton, Niall Quinn, Henry Houlden, Viorica Chelban

Summary: This article is a practical guide to diagnosing and managing multiple system atrophy (MSA). It explains the newly published Movement Disorders Society Consensus Diagnostic Criteria, which aim to reduce time to diagnosis. The key clinical features of MSA are highlighted to aid in diagnosis. The article also discusses practical symptom management and improving quality of life for people with MSA.

PRACTICAL NEUROLOGY (2023)

Article Clinical Neurology

Chronic effects of inflammation on tauopathies

Connor Langworth-Green, Saisha Patel, Zane Jaunmuktane, Edwin Jabbari, Huw Morris, Maria Thom, Andrew Lees, John Hardy, Michael Zandi, Karen Duff

Summary: Tauopathies are neurodegenerative disorders characterized by the aggregation of tau protein. Chronic inflammation plays a significant role in the pathogenesis of Alzheimer's disease, but its effects on tau pathology have been overlooked. Factors such as infection, brain injury, seizures, and autoimmune disease can trigger tau pathology through inflammatory processes. Understanding the chronic effects of inflammation on tauopathies may lead to the development of immunomodulatory interventions for clinical use.

LANCET NEUROLOGY (2023)

暂无数据